Standout Papers

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated <i>KRAS</i> G12C 2023 2026 2024140
  1. Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C (2023)
    Marwan Fakih, Lisa Salvatore et al. New England Journal of Medicine

Immediate Impact

54 standout
Sub-graph 1 of 24

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Targeting KRAS in cancer
2024 Standout
1 intermediate paper

Works of Fausto Meriggi being referenced

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer: still hope after the last hope?
2016

Author Peers

Author Last Decade Papers Cites
Fausto Meriggi 391 178 82 132 63 590
KC Lakshmaiah 311 180 109 78 72 533
Olumide B. Gbolahan 293 164 56 108 63 714
Ross Jennens 318 213 42 108 45 596
Ravi Kumar Paluri 314 133 47 109 63 661
Shuncong Wang 337 203 52 203 38 738
K C Lakshmaiah 305 177 90 104 27 524
Ignazio Carreca 352 173 74 175 34 690
L. Cals 479 250 61 75 40 648
Aya Nakaya 284 128 64 99 54 581
Serkan Keskın 407 229 46 112 60 676

All Works

Loading papers...

Rankless by CCL
2026